SERPINB2 and ovarian carcinoma: Several reports have shown that plasminogen activator inhibitor-2 (PAI-2), a protein capable of inhibiting invasion (Andreasen et al, 2000), may represent a molecular biomarker for several human tumours including ovarian carcinomas.